Eleftheria Maratos-Flier

Eleftheria Maratos-Flier is an American endocrinologist, and emerita Professor of Medicine at Harvard Medical School, best known for her expertise in the pathophysiology and prevention of obesity-related metabolic disorders, and for her discoveries on the neuroendocrine control of feeding behaviour.

She is a contributing author to known textbooks and reviews in internal medicine, endocrinology, and physiology.

Her marriage with professor Jeffrey Flier, was noted by Forbes as a lasting and productive bond between eminent medical scholars.

They have two adult daughters who are also physicians.

She is also known as Terry Maratos-Flier.

In 1972, she graduated with a BA in Chemistry from New York University, New York, NY.

In 1976, she graduated as an MD from the Mount Sinai School of Medicine, New York, NY, followed by internship and residency training in internal medicine at George Washington University Hospital, Washington, DC.

In Massachusetts (1978-1981), she pursued further residency training in internal medicine at Beth Israel Hospital, postdoctoral research fellowship at Harvard School of Public Health, and Clinical Fellowship at the Joslin Diabetes Center and Brigham and Women’s Hospital.

Since 1982 she has taught at Harvard Medical School, becoming a full Professor of Medicine from 2010 to 2018, when she became professor emerita.

She has been an associate member of the Broad Institute, and a Principal Investigator of many NIH-funded research grants.

She has also been an attending endocrinologist at Beth Israel Deaconess Medical Center, where she still provides care for patients with metabolic disease.

She also authored the obesity chapters of the 20th edition of Harrison's Principles of Internal Medicine (jointly with Jeffrey Flier), and the 14th edition of Williams Textbook of Endocrinology. In 2016, she contributed an article to the Annual Review of Physiology on the physiology of Fibroblast Growth Factor 21.

Maratos-Flier's research papers have been cited over 15,600 times.

Her most cited papers are:

From 2018, she has been Director, Translational Medicine, at Novartis Institutes of Biomedical Research, Cambridge, MA., recently moving to Alnylam to serve as a director of clinical research.

She has authored more than 100 peer-reviewed papers, most of them studying aspects of obesity and type II diabetes in experimental mouse models, and also in clinical disease.